SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : King Pharmaceuticals, Inc. (Nasdaq:KG)(Was KING)
KG 23.52-4.6%Oct 29 3:59 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: wpckr who wrote (20)5/27/1999 1:59:00 PM
From: Harold Engstrom  Read Replies (2) of 61
 
I don't like the look of the balance sheet for KING. Very low on cash, its intangible assets make up the majority of assets, its liablilities are nearly the size of the assets and consist primarily of loans, and with hard currency liabilities far outweighing cash or marketable securities the company doesn't have much flexibility to deal with potential crises.

As pharmaceutical companies go, this one looks riskier than many. What is the upside here that outweighs the risks.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News